Chun‐Hung Chan

912 total citations
25 papers, 674 citations indexed

About

Chun‐Hung Chan is a scholar working on Molecular Biology, Genetics and Physiology. According to data from OpenAlex, Chun‐Hung Chan has authored 25 papers receiving a total of 674 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Genetics and 6 papers in Physiology. Recurrent topics in Chun‐Hung Chan's work include Genomics and Rare Diseases (6 papers), Lysosomal Storage Disorders Research (6 papers) and Cancer Genomics and Diagnostics (4 papers). Chun‐Hung Chan is often cited by papers focused on Genomics and Rare Diseases (6 papers), Lysosomal Storage Disorders Research (6 papers) and Cancer Genomics and Diagnostics (4 papers). Chun‐Hung Chan collaborates with scholars based in United States, France and Hong Kong. Chun‐Hung Chan's co-authors include John G. Parnavelas, David A. Pearce, Myrto Denaxa, Domna Karagogeos, Melitta Schachner, Yuan‐Ting Zhang, Zoltán Molnár, Guillermina López‐Bendito, Antonello Mallamaci and Norman Miller and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Chun‐Hung Chan

23 papers receiving 660 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chun‐Hung Chan United States 15 227 203 166 139 135 25 674
Andrew P. Tosolini United Kingdom 15 396 1.7× 367 1.8× 98 0.6× 73 0.5× 138 1.0× 25 852
Denise Davis United States 9 169 0.7× 250 1.2× 97 0.6× 57 0.4× 73 0.5× 30 633
Renata Vieira de Sá Netherlands 9 398 1.8× 185 0.9× 168 1.0× 76 0.5× 32 0.2× 11 819
Marta Radaelli Italy 25 199 0.9× 104 0.5× 78 0.5× 85 0.6× 37 0.3× 61 1.6k
Isabelle Scheyltjens Belgium 15 405 1.8× 261 1.3× 142 0.9× 119 0.9× 27 0.2× 20 1.5k
Fuyi Chen United States 13 364 1.6× 160 0.8× 118 0.7× 93 0.7× 35 0.3× 25 793
Emma J. van Bodegraven Netherlands 15 518 2.3× 128 0.6× 197 1.2× 100 0.7× 75 0.6× 19 875
Derek Lumbard United States 11 188 0.8× 260 1.3× 87 0.5× 92 0.7× 278 2.1× 19 682
Judy S. Liu United States 10 309 1.4× 281 1.4× 265 1.6× 32 0.2× 173 1.3× 16 746
Namita Ravi United States 4 555 2.4× 298 1.5× 45 0.3× 78 0.6× 54 0.4× 5 978

Countries citing papers authored by Chun‐Hung Chan

Since Specialization
Citations

This map shows the geographic impact of Chun‐Hung Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun‐Hung Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun‐Hung Chan more than expected).

Fields of papers citing papers by Chun‐Hung Chan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chun‐Hung Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun‐Hung Chan. The network helps show where Chun‐Hung Chan may publish in the future.

Co-authorship network of co-authors of Chun‐Hung Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Chun‐Hung Chan. A scholar is included among the top collaborators of Chun‐Hung Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chun‐Hung Chan. Chun‐Hung Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Groza, Tudor, Chun‐Hung Chan, David A. Pearce, & Gareth Baynam. (2024). Realising the potential impact of artificial intelligence for rare diseases – A framework. SHILAP Revista de lepidopterología. 3. 100057–100057.
3.
4.
Garrido‐Estepa, Macarena, Daniel O’Connor, Rima Nabbout, et al.. (2023). Targeting shared molecular etiologies to accelerate drug development for rare diseases. EMBO Molecular Medicine. 15(7). e17159–e17159. 19 indexed citations
5.
Chan, Chun‐Hung, Samantha Parker, & David A. Pearce. (2023). The international rare disease research consortium (IRDiRC): making rare disease research efforts more efficient and collaborative around the world. 2(4). 28–28. 1 indexed citations
6.
Chan, Chun‐Hung, et al.. (2022). Recommendations from the IRDiRC Working Group on methodologies to assess the impact of diagnoses and therapies on rare disease patients. Orphanet Journal of Rare Diseases. 17(1). 181–181. 20 indexed citations
7.
Wang, Chiuhui Mary, Daria Julkowska, Chun‐Hung Chan, David A. Pearce, & Lucía Monaco. (2021). COVID-19 and rare diseases: reflections and recommendations by the International Rare Diseases Research Consortium. 2 indexed citations
8.
Cutillo, Christine M., Pierantonio Russo, Bryan Laraway, et al.. (2021). The IDeaS initiative: pilot study to assess the impact of rare diseases on patients and healthcare systems. Orphanet Journal of Rare Diseases. 16(1). 429–429. 53 indexed citations
9.
Powell, Steven, Elie G. Dib, Jonathan Bleeker, et al.. (2018). Delivering Precision Oncology in a Community Cancer Program: Results From a Prospective Observational Study. JCO Precision Oncology. 2(2). 1–12. 4 indexed citations
10.
So, Wing‐Chee, et al.. (2017). Using a social robot to teach gestural recognition and production in children with autism spectrum disorders. Disability and Rehabilitation Assistive Technology. 13(6). 527–539. 48 indexed citations
11.
Beraldi, Rosanna, Chun‐Hung Chan, Christopher S. Rogers, et al.. (2015). A novel porcine model of ataxia telangiectasia reproduces neurological features and motor deficits of human disease. Human Molecular Genetics. 24(22). 6473–6484. 33 indexed citations
12.
Kovács, Attila, et al.. (2013). Osmotic Stress Changes the Expression and Subcellular Localization of the Batten Disease Protein CLN3. PLoS ONE. 8(6). e66203–e66203. 26 indexed citations
13.
Beneš, Francine M., et al.. (2013). How Is Your Biobank Handling Disaster Recovery Efforts?. Biopreservation and Biobanking. 11(4). 194–201. 2 indexed citations
14.
Miller, Norman, Chun‐Hung Chan, & David A. Pearce. (2013). The role of nonsense-mediated decay in neuronal ceroid lipofuscinosis. Human Molecular Genetics. 22(13). 2723–2734. 36 indexed citations
15.
Padilla‐Lopez, Sergio, et al.. (2011). BTN1, the Saccharomyces cerevisiae homolog to the human Batten disease gene, is involved in phospholipid distribution. Disease Models & Mechanisms. 5(2). 191–199. 15 indexed citations
16.
Ramirez‐Montealegre, Denia, Chun‐Hung Chan, Julian A. Castaneda, et al.. (2010). Immunosuppression alters disease severity in juvenile Batten disease mice. Journal of Neuroimmunology. 230(1-2). 169–172. 66 indexed citations
17.
19.
Chan, Chun‐Hung & Hermes H. Yeh. (2003). Enhanced GABAA Receptor‐Mediated Activity Following Activation of NMDA Receptors in Cajal‐Retzius Cells in the Developing Mouse Neocortex. The Journal of Physiology. 550(1). 103–111. 17 indexed citations
20.
López‐Bendito, Guillermina, Chun‐Hung Chan, Antonello Mallamaci, John G. Parnavelas, & Zoltán Molnár. (2002). Role of Emx2 in the development of the reciprocal connectivity between cortex and thalamus. The Journal of Comparative Neurology. 451(2). 153–169. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026